Skip to main content

US ClosedU.S. Closed

AZTR: Azitra, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions.

52W Range

8thpctl

Volume

0.09×avg

Market Cap

1.90MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Azitra, Inc.

AZTRNew York Stock Exchange Arca·USD·Closed

Azitra, Inc.

AZTRNew York Stock Exchange Arca·USD·Closed

$0.18

−4.79%

$0.18

−$0.01 (4.79%)

52W Range

8thpctl

Volume

0.09×avg

Mkt Cap

1.90MUSD

P/E

-0.1TTM

Div Yield

–ann